Form 8-K - Current report:
SEC Accession No. 0001493152-23-038668
Filing Date
2023-10-30
Accepted
2023-10-30 16:05:19
Documents
12
Period of Report
2023-10-29
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 32816
  Complete submission text file 0001493152-23-038668.txt   200898

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ppcb-20231029.xsd EX-101.SCH 3012
3 XBRL LABEL FILE ppcb-20231029_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ppcb-20231029_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3109
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 330662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54878 | Film No.: 231360206
SIC: 2834 Pharmaceutical Preparations